Cargando…

Cardiovascular and Venous Thromboembolic Risk With Janus Kinase Inhibitors in Immune‐Mediated Inflammatory Diseases: A Systematic Review and Meta‐Analysis of Randomized Trials

OBJECTIVE: Janus kinase (JAK) inhibition effectively treats immune‐mediated inflammatory diseases (IMIDs); however, concern over the risk of major adverse cardiac events (MACE) and venous thromboembolism (VTE) remains. We aimed to evaluate the safety (VTE and MACE outcomes) of JAK inhibitors in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maqsood, Muhammad Haisum, Weber, Brittany N., Haberman, Rebecca H., Lo Sicco, Kristen I., Bangalore, Sripal, Garshick, Michael S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555201/ https://www.ncbi.nlm.nih.gov/pubmed/35903881 http://dx.doi.org/10.1002/acr2.11479

Ejemplares similares

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis
por: Zhang, Juqi, et al.
Publicado: (2023)

Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery
por: Smilowitz, Nathaniel R., et al.
Publicado: (2017)

Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review
por: Mori, Shunsuke, et al.
Publicado: (2021)

Cardiovascular Issues Among Homeless People: An Issue that Needs Attention
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2020)

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
por: Devabhaktuni, Madhuri, et al.
Publicado: (2009)

Cardiovascular Risk Factors: It's Time to Focus on Variability!
por: Barnett, Mallory P., et al.
Publicado: (2020)

Saddle pulmonary embolism and clot in transit in COVID-19 infection: a case report of catastrophic venous thromboembolism
por: Aoi, Shunsuke, et al.
Publicado: (2020)

Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk
por: Rajasimhan, Suraj, et al.
Publicado: (2020)

The Role of Revefenacin in Chronic Obstructive Pulmonary Disease
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019)

Clinical Efficacy and Safety Profile of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019)

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: De Vries, L.C.S., et al.
Publicado: (2017)

Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases
por: Núñez, Paulina, et al.
Publicado: (2023)

Quality of Life of Patients Using the Hemodialysis Reliable Outflow (HeRO) Graft in Hemodialysis
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019)

The Role of the Cardioversion Defibrillator in Post Myocardial Infarction Sudden Cardiac Death: A Systematic Review of Clinical Trials and Observational Studies
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019)

Venous thromboembolism in inflammatory bowel disease
por: Cheng, Kimberly, et al.
Publicado: (2020)

Cardiovascular Risk Factors Associated With Venous Thromboembolism
por: Gregson, John, et al.
Publicado: (2019)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)

Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019
por: Aggarwal, Gaurav, et al.
Publicado: (2020)

Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: Lefevre, Pavine L C, et al.
Publicado: (2020)

The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment
por: Kim, Jin-Woo, et al.
Publicado: (2021)

Molecular dissection of Janus kinases as drug targets for inflammatory diseases
por: Kwon, Sunghark
Publicado: (2022)

Itch and Janus Kinase Inhibitors
por: HAN, Yujin, et al.
Publicado: (2023)

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?
por: Kotyla, Przemysław J., et al.
Publicado: (2021)

Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease
por: Siegmund, Britta
Publicado: (2020)

Commentary: Janus kinase inhibitors and their use in autoimmune ocular inflammatory disorders
por: Moreker, Mayur R
Publicado: (2020)

Hidradenitis suppurativa is associated with iron deficiency anemia, anemia of chronic disease, and sickle cell anemia—A single-center retrospective cohort study
por: Parameswaran, Anupama, et al.
Publicado: (2021)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Venous and arterial thromboembolism in patients with inflammatory bowel diseases
por: Stadnicki, Antoni, et al.
Publicado: (2021)

CDC-WONDER Database Analysis of COVID-19 and Cardiovascular Disease-Related Mortality
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2023)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Authors’ Reply to Moura et al.: “Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk”
por: Rajasimhan, Suraj, et al.
Publicado: (2021)

Association between cardiovascular risk factors and venous thromboembolism in the elderly
por: Wang, Huijie, et al.
Publicado: (2022)

The State of Coronary Thrombus Aspiration
por: Pruthi, Sonal, et al.
Publicado: (2022)

Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012)

Janus Kinase Inhibitors and Cell Therapy
por: Assal, Amer, et al.
Publicado: (2021)

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
por: Kotyla, Przemysław J., et al.
Publicado: (2020)

Obesity, pregnancy, and prophylaxis for venous thromboembolism
por: Nawaz, Iqra, et al.
Publicado: (2023)

Elevated risk of venous thromboembolic events in patients with inflammatory myopathies
por: Nowak, Michał, et al.
Publicado: (2016)

Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups
por: Kaddourah, Osama, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4138bchoiv7l42tr9cfe9kivar